| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 16 | |
| #2 | Israel | 15 | |
| #3 | Australia | 11 | |
| #4 | Brazil | 11 | |
| #5 | Canada | 11 | |
| #6 | China | 11 | |
| #7 | Mexico | 11 | |
| #8 | Republic of Korea | 9 | |
| #9 | Norway | 9 | |
| #10 | WIPO (World Intellectual Property Organization) | 9 | |
| #11 | Hong Kong | 8 | |
| #12 | United States | 8 | |
| #13 | South Africa | 8 | |
| #14 | New Zealand | 7 | |
| #15 | Taiwan | 5 | |
| #16 | Argentina | 4 | |
| #17 | Morocco | 4 | |
| #18 | Peru | 4 | |
| #19 | Chile | 3 | |
| #20 | Jordan | 3 | |
| #21 | Japan | 3 | |
| #22 | Malaysia | 3 | |
| #23 | Singapore | 3 | |
| #24 | Tunisia | 3 | |
| #25 | Ecuador | 2 | |
| #26 | Ukraine | 2 | |
| #27 | Colombia | 1 | |
| #28 | Saudi Arabia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Medical technology | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Steroids | |
| #5 | Electrotherapy | |
| #6 | Special acyclic compounds | |
| #7 | Fermentation | |
| #8 | Sugars | |
| #9 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Castro Alfredo C | 103 |
| #2 | Grogan Michael J | 84 |
| #3 | Holson Edward B | 69 |
| #4 | Snyder Daniel A | 60 |
| #5 | Hopkins Brian T | 59 |
| #6 | Koney Nii O | 58 |
| #7 | Peluso Stephane | 44 |
| #8 | Porter James R | 37 |
| #9 | Tibbitts Thomas T | 35 |
| #10 | Wright James L | 31 |
| Publication | Filing date | Title |
|---|---|---|
| TW201006484A | Isolation of cyclopamine | |
| ZA200903440B | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
| MX2009010808A | Hydroquinone ansamycin formulations. | |
| EP2129677A1 | Heterocyclic cyclopamine analogs and methods of use thereof | |
| US2010099116A1 | Methods for Analysis of Hedgehog Pathway Inhibitors | |
| UA97130C2 | Cyclopamine derivatives | |
| TW200848034A | Cyclopamine analogs | |
| AU2007332727A1 | Ansamycin formulations and methods of use thereof | |
| JO3598B1 | Boronic acids and esters as inhibitors of fatty acid amide hydrolase | |
| TW200817346A | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
| TW200811100A | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |